首页> 外文期刊>Frontiers in Oncology >Bioinformatics Identified 17 Immune Genes as Prognostic Biomarkers for Breast Cancer: Application Study Based on Artificial Intelligence Algorithms
【24h】

Bioinformatics Identified 17 Immune Genes as Prognostic Biomarkers for Breast Cancer: Application Study Based on Artificial Intelligence Algorithms

机译:生物信息学确定了17个免疫基因,作为乳腺癌的预后生物标志物:基于人工智能算法的应用研究

获取原文
       

摘要

An increasing body of evidence supports the association of immune genes with tumorigenesis and prognosis of breast cancer (BC). This research aims at exploring potential regulatory mechanisms and identifying immunogenic prognostic markers for BC, which were used to construct a prognostic signature for disease-free survival (DFS) of BC based on artificial intelligence algorithms. Differentially expressed immune genes were identified between normal tissues and tumor tissues. Univariate Cox regression identified potential prognostic immune genes. Thirty-four transcription factors and 34 immune genes were used to develop an immune regulatory network. The artificial intelligence survival prediction system was developed based on three artificial intelligence algorithms. Multivariate Cox analyses determined 17 immune genes (ADAMTS8, IFNG, XG, APOA5, SIAH2, C2CD2, STAR, CAMP, CDH19, NTSR1, PCDHA1, AMELX, FREM1, CLEC10A, CD1B, CD6, and LTA) as prognostic biomarkers for BC. A prognostic nomogram was constructed on these prognostic genes. Concordance indexes were 0.782, 0.734, and 0.735 for 1-, 3-, and 5- year DFS. The DFS in high-risk group was significantly worse than that in low-risk group. Artificial intelligence survival prediction system provided three individual mortality risk predictive curves based on three artificial intelligence algorithms. In conclusion, comprehensive bioinformatics identified 17 immune genes as potential prognostic biomarkers, which might be potential candidates of immunotherapy targets in BC patients. The current study depicted regulatory network between transcription factors and immune genes, which was helpful to deepen the understanding of immune regulatory mechanisms for BC cancer. Two artificial intelligence survival predictive systems are available at https://zhangzhiqiao7.shinyapps.io/Smart_Cancer_Survival_Predictive_System_16_BC_C1005/ and https://zhangzhiqiao8.shinyapps.io/Gene_Survival_Subgroup_Analysis_16_BC_C1005/ . These novel artificial intelligence survival predictive systems will be helpful to improve individualized treatment decision-making.
机译:越来越多的证据支持免疫基因与乳腺癌肿瘤鉴定和预后的关联(BC)。该研究旨在探索潜在的调节机制并鉴定BC的免疫原性预后标志物,其用于构建基于人工智能算法的BC的无病生存(DFS)的预后签名。在正常组织和肿瘤组织之间鉴定了差异表达的免疫基因。单变量Cox回归鉴定了潜在的预后免疫基因。三十四个转录因子和34种免疫基因用于开发免疫调节网络。人工智能生存预测系统是基于三个人工智能算法开发的。多元COX分析确定了17个免疫基因(Adamts8,IFNG,XG,ApoA5,SiaH2,C2CD2,星,营,CDH19,NTSR1,PCDHA1,AMELX,FREM1,CLEC10A,CD1B,CD6和LTA)作为BC的预后生物标志物。在这些预后基因上构建了预后的NOM图。 1-,3-和5年DFS的一致性指数为0.782,0.734和0.735。高风险组的DFS明显差,低风险群体。人工智能生存预测系统提供了基于三个人工智能算法的三种单独死亡风险预测曲线。总之,综合生物信息学确定了17个免疫基因作为潜在的预后生物标志物,这可能是BC患者免疫疗法靶标的潜在候选者。目前的研究描述了转录因子和免疫基因之间的监管网络,这有助于加深对BC癌症的免疫调节机制的理解。在https.io/smart_cancer_survival_priveictive_system_16_bc_c1005/和https://zhangzhiqiao8.shinyapps.io/gene_survival_subgroup_analysis_16_bc_analysis_16_bc_c1005/这些新颖的人工智能生存预测系统将有助于改善个性化治疗决策。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号